Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

CU-CPT9b

Copy Product Info
😃Good
Catalog No. T7302Cas No. 2162962-69-6
Alias TLR8-specific antagonist 1, CU-CPT-9b

CU-CPT9b (TLR8-specific antagonist 1) is an antagonist of toll-like receptor 8 (TLR8; Kd = 21 nM). It inhibits activation of NF- B induced by the TLR8 agonist R-848 in TLR8-overexpressing HEK-Blue cells with an IC50 value of 0.7 nM.

CU-CPT9b

CU-CPT9b

Copy Product Info
😃Good
Purity: 98.1%
Catalog No. T7302Alias TLR8-specific antagonist 1, CU-CPT-9bCas No. 2162962-69-6
CU-CPT9b (TLR8-specific antagonist 1) is an antagonist of toll-like receptor 8 (TLR8; Kd = 21 nM). It inhibits activation of NF- B induced by the TLR8 agonist R-848 in TLR8-overexpressing HEK-Blue cells with an IC50 value of 0.7 nM.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$44In StockIn Stock
5 mg$98In StockIn Stock
10 mg$163In StockIn Stock
25 mg$272In StockIn Stock
50 mg$378In StockIn Stock
100 mg$559In StockIn Stock
200 mg$796-In Stock
1 mL x 10 mM (in DMSO)$113In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.1%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

CU-CPT9b AI Summary
CU-CPT9b exhibits antagonist activity at human TLR8, particularly when R848 stimulates TLR8 overexpressed in HEK293 cells. Its bioactivity, measured through a SEAP reporter assay, demonstrates an IC50 value of 0.7 nM. Additionally, the compound has a binding affinity with a Kd of 21.0 nM, showcasing its potent inhibitory properties..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
CU-CPT9b (TLR8-specific antagonist 1) is an antagonist of toll-like receptor 8 (TLR8; Kd = 21 nM). It inhibits activation of NF- B induced by the TLR8 agonist R-848 in TLR8-overexpressing HEK-Blue cells with an IC50 value of 0.7 nM.
Targets&IC50
TLR8:0.7 nM (IC50), TLR8:21 nM (Kd)
SynonymsTLR8-specific antagonist 1, CU-CPT-9b
Chemical Properties
Molecular Weight251.28
FormulaC16H13NO2
Cas No.2162962-69-6
SmilesCc1cc(ccc1O)-c1ccnc2cc(O)ccc12
Relative Density.1.287 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 100 mg/mL (397.96 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (15.92 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.9796 mL19.8981 mL39.7962 mL198.9812 mL
5 mM0.7959 mL3.9796 mL7.9592 mL39.7962 mL
10 mM0.3980 mL1.9898 mL3.9796 mL19.8981 mL
20 mM0.1990 mL0.9949 mL1.9898 mL9.9491 mL
50 mM0.0796 mL0.3980 mL0.7959 mL3.9796 mL
100 mM0.0398 mL0.1990 mL0.3980 mL1.9898 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy CU-CPT9b | purchase CU-CPT9b | CU-CPT9b cost | order CU-CPT9b | CU-CPT9b chemical structure | CU-CPT9b formula | CU-CPT9b molecular weight